CIK 0001533743 · <br>Emerging growth company
Processa Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PCSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 451539785
- Phone
- 443-776-3133
- Business address
- 601 21ST STREET, SUITE 300, VERO BEACH, FL, 32960
- Former names
- Heatwurx, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-05 | Bigora Sian Chief Development Officer | Option exercise | +1,675 | 21,827 | ||
| 2024-04-05 | Bigora Sian Chief Development Officer | Shares withheld for taxes | −368 | $2.79 | $1K | 21,459 |
| 2024-04-05 | Stanker James H Chief Financial Officer | Option exercise | +1,675 | 6,638 | ||
| 2024-04-05 | Stanker James H Chief Financial Officer | Shares withheld for taxes | −518 | $2.79 | $1K | 6,120 |
| 2024-04-05 | Lin Patrick Chief Business - Strategy Off | Option exercise | +1,675 | 29,225 | ||
| 2024-04-05 | Lin Patrick Chief Business - Strategy Off | Shares withheld for taxes | −539 | $2.79 | $2K | 28,686 |
| 2024-04-05 | Guy Wendy Chief Administrative Officer | Option exercise | +1,675 | 11,801 | ||
| 2024-04-05 | Guy Wendy Chief Administrative Officer | Shares withheld for taxes | −368 | $2.79 | $1K | 11,433 |
| 2024-04-05 | Young David Pres. Research & Development | Option exercise | +1,675 | 81,061 | ||
| 2024-04-05 | Young David Pres. Research & Development | Shares withheld for taxes | −518 | $2.79 | $1K | 80,543 |
| 2024-02-07 | Young David Pres. Research & Development | Purchase | +21,000 | $2.45 | $52K | 79,387 |
| 2024-02-06 | Young David Pres. Research & Development | Purchase | +20,000 | $2.53 | $51K | 58,387 |
| 2024-02-01 | Lin Patrick Chief Business - Strategy Off | Purchase | +1,500 | $2.40 | $4K | 27,478 |
| 2024-01-31 | Lin Patrick Chief Business - Strategy Off | Purchase | +2,500 | $2.37 | $6K | 25,978 |
| 2024-01-30 | Ng George K Chief Executive Officer | Purchase | +10,000 | $2.70 | $27K | 20,000 |
| 2024-01-30 | Yorke Justin W Director | Purchase | +8,000 | $2.69 | $22K | 31,232 |
| 2024-01-01 | Young David Pres. Research & Development | Option exercise | +1,675 | 81,062 | ||
| 2024-01-01 | Young David Pres. Research & Development | Shares withheld for taxes | −518 | $2.79 | $1K | 80,544 |
| 2024-01-01 | Young David Pres. Research & Development | Option exercise · Restricted Stock Units | −1,675 | 19,333 | ||
| 2024-01-01 | Stanker James H Chief Financial Officer | Option exercise | +1,675 | 6,638 |
Page 9 of 15 · 298 trades